𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-Term Risk of Adverse Outcomes and New Malignancies in Patients Treated With Oral Sirolimus for Prevention of Restenosis

✍ Scribed by Sebastian Kufner; Jörg Hausleiter; Gjin Ndrepepa; Stefanie Schulz; Olga Bruskina; Robert A. Byrne; Massimiliano Fusaro; Adnan Kastrati; Albert Schömig; Julinda Mehilli

Book ID
108161451
Publisher
American College of Cardiology
Year
2009
Tongue
English
Weight
422 KB
Volume
2
Category
Article
ISSN
1936-8798

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized trial of fenretinide (4-HPR)
Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: Long-term results
✍ Fausto Chiesa; Nicoletta Tradati; Roberto Grigolato; Patrizia Boracchi; Elia Big 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB

## Abstract We assessed the efficacy of fenretinide at preventing relapses, new lesions and carcinomas after surgical excision of oral leukoplakia. In a controlled multicenter study, 170 patients operated on for oral leukoplakias with benign postoperative histology were randomized to 200 mg fenreti